BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20667157)

  • 1. Severe respiratory and skeletal muscles involvement in a carrier of dysferlinopathy with chronic obstructive pulmonary disease.
    Fuschillo S; Torrente Y; Balzano G
    Respir Care; 2010 Aug; 55(8):1091-3. PubMed ID: 20667157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of dysferlinopathy presenting choreic movements.
    Takahashi T; Aoki M; Imai T; Yoshioka M; Konno H; Higano S; Onodera Y; Saito H; Kimura I; Itoyama Y
    Mov Disord; 2006 Sep; 21(9):1513-5. PubMed ID: 16817213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
    Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
    Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic investigation of the molecular pathophysiology of dysferlinopathy.
    De Palma S; Morandi L; Mariani E; Begum S; Cerretelli P; Wait R; Gelfi C
    Proteomics; 2006 Jan; 6(1):379-85. PubMed ID: 16302276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
    Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
    Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
    Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
    Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy.
    Sinnreich M; Therrien C; Karpati G
    Neurology; 2006 Apr; 66(7):1114-6. PubMed ID: 16606933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysferlin and muscular dystrophy.
    Bushby KM
    Acta Neurol Belg; 2000 Sep; 100(3):142-5. PubMed ID: 11098285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
    Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
    J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
    Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
    Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of podocyte dysferlin expression is associated with minimal change nephropathy.
    Izzedine H; Brocheriou I; Eymard B; Le Charpentier M; Romero NB; Lenaour G; Bourry E; Deray G
    Am J Kidney Dis; 2006 Jul; 48(1):143-50. PubMed ID: 16797397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete fatty degeneration of lumbar erector spinae muscles caused by a primary dysferlinopathy.
    Seror P; Krahn M; Laforet P; Leturcq F; Maisonobe T
    Muscle Nerve; 2008 Mar; 37(3):410-4. PubMed ID: 17932988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype.
    Illa I; Serrano-Munuera C; Gallardo E; Lasa A; Rojas-García R; Palmer J; Gallano P; Baiget M; Matsuda C; Brown RH
    Ann Neurol; 2001 Jan; 49(1):130-4. PubMed ID: 11198284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis.
    Lo HP; Cooper ST; Evesson FJ; Seto JT; Chiotis M; Tay V; Compton AG; Cairns AG; Corbett A; MacArthur DG; Yang N; Reardon K; North KN
    Neuromuscul Disord; 2008 Jan; 18(1):34-44. PubMed ID: 17897828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral health considerations in muscular dystrophies.
    Balasubramaniam R; Sollecito TP; Stoopler ET
    Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Respiratory system elastance and resistance measured by proportional assist ventilation in patients with respiratory muscle weakness].
    Oya Y; Ogawa M; Kawai M
    Rinsho Shinkeigaku; 2004; 44(4-5):268-73. PubMed ID: 15287508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel sequence variants in dysferlin-deficient muscular dystrophy leading to mRNA decay and possible C2-domain misfolding.
    Wenzel K; Carl M; Perrot A; Zabojszcza J; Assadi M; Ebeling M; Geier C; Robinson PN; Kress W; Osterziel KJ; Spuler S
    Hum Mutat; 2006 Jun; 27(6):599-600. PubMed ID: 16705711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.